CELH
Celsius Holdings, Inc.
CELH has the edge over TBBB overall, supported by stronger fundamentals and stronger valuation.
TBBB
BBB Foods Inc.
TBBB has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
TBBB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Healthy | |
| Weak |
TBBB's revenue and cash flow are currently healthy, but its profitability and balance sheet are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
TBBB PE Valuation
TBBB has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
TBBB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect TBBB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over TBBB on earnings quality, reporting a profit while its opponent remains loss making.
TBBB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.56 | -$1.48 |
| Q1 2026 | -$1.52 | -824% |
| Q4 2025 | -$1.30 | -1400% |
| Q3 2025 | -$0.84 | -1780% |
| Q2 2025 | -$0.08 | +$0.19 |
| Q1 2025 | $0.21 | +$0.59 |
| Q4 2024 | $0.10 | +$0.30 |
| Q3 2024 | $0.05 | +$0.17 |
TBBB lost $1.56 per share over the past year, and its loss has widened in each of the last five quarters.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over TBBB on profitability, with a higher operating margin.
TBBB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.4B | +39% |
| Q1 2026 | $1.2B | +33% |
| Q4 2025 | $1.2B | +32% |
| Q3 2025 | $1.1B | +35% |
| Q2 2025 | $1B | +38% |
| Q1 2025 | $919.2M | +35% |
| Q4 2024 | $877.1M | +35% |
| Q3 2024 | $795.9M | +30% |
TBBB's revenue has grown year over year every quarter since late 2023: $1.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 1.3% | -0.8 points |
| Q1 2026 | -0.1% | -1.8 points |
| Q4 2025 | -1.3% | -3 points |
| Q3 2025 | -4.4% | -6.8 points |
| Q2 2025 | 2.1% | -0.7 points |
| Q1 2025 | 1.7% | -0.8 points |
| Q4 2024 | 1.7% | -0.4 points |
| Q3 2024 | 2.4% | +0.5 points |
TBBB's operating margin was 1.3% last quarter, down 0.8 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
TBBB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $74.6M | +$81M |
| Q1 2026 | $66.9M | +93% |
| Q4 2025 | $21.1M | -32% |
| Q3 2025 | $11.3M | -53% |
| Q2 2025 | -$6.4M | +$1.4M |
| Q1 2025 | $34.7M | +55% |
| Q4 2024 | $30.9M | +70% |
| Q3 2024 | $24M | -37% |
TBBB has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over TBBB on leverage, with a lower net debt burden relative to earnings.
TBBB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 12.0x | High |
| Q1 2026 | 15.1x | High |
| Q4 2025 | 12.3x | High |
| Q3 2025 | 5.5x | High |
| Q2 2025 | 2.8x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.3x | Moderate |
| Q3 2024 | 2.3x | Moderate |
TBBB's net debt is about 12 years of its operating earnings (EBITDA), up from 2.8 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
TBBB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 83.1 | Overbought |
| Stochastic | 94.4 | Overbought |
TBBB's weekly RSI is 83 (overbought) and its Stochastic is 94 (overbought).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
TBBB PE vs Consumer Defensive Sector
| Metric | TBBB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
TBBB has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
TBBB has stronger trend alignment. CELH is above 2 of 5 weekly averages versus TBBB above 4 of 4.
TBBB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.5 | 16% above |
| 20 week MA | $50.8 | 34% above |
| 50 week MA | $42.1 | 62% above |
| 100 week MA | $34.8 | 95% above |
TBBB is in an uptrend: it's above all four of its weekly moving averages, and 95% above its 100-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
TBBB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.1 | $29.3 | +54% |
| 2025 | $29.3 | $34.3 | +17% |
| 2026 YTD | $34.3 | $68.0 | +98% |
TBBB has the edge over CELH on returns for 2026, with the stronger performance.